As cannabis becomes more researched, more accepted, and more available, so too are cannabinoids other than THC being spoken about and sought after.
THC is the cannabinoid that the most people are familiar with, and its associated with the psychoactive effect that you get from smoking weed. CBD has also become a household name, both for its legal status – nearly, around the world – as well as for its potential medical benefits and modulation of the way that THC effects physiology when ingested in combination.
Many fewer are familiar with CBDa or CBGa, however these two compounds have recently turned up with more frequency in conversations regarding the medical benefits of cannabis. Remember, that there are well over 100 natural-occurring cannabinoids and each one of them as well as their combinations have potentials for all sorts of medical benefits in humans, thanks to their interaction with the endocannabinoid system.
In this article we’re going to take a closer look at these two specific cannabinoids, CBGa, and CBDa, how they might effect our system and why they are so interesting and talked about in medical circles. Spoiler alert: Part of what makes these two cannabinoids so interesting is their potential connection to prevention of Covid-19.
Lets refresh our memories. The endocannabinoid system refers to a series of cannabinoid receptors that are found naturally in all mammals including humans and these receptors are found in our central nervous system and peripheral nervous system. These receptors are the reason why cannabinoids have an ability to effect us in the first place! Endocannabinoids are the cannabinoids which our bodies make on their own, while we refer to the cannabinoids we find in nature – the ones found on the cannabis plant – as phytocannabinoids.
Cannabinoids, as well as the endocannabinoid system, are presently being investigated for their involvement in some pretty basic bodily functions like memory, appetite, energy balance and metabolism, stress response, the immune system, the female reproductive system, analgesia and pain relief, thermal regulation, sleep, and more. The take-away is quite simply that the endocannabinoid system is deeply rooted in so many life functions that it’s no wonder phytocannabinoids might have a potential for treating problems related to these functions.
Different cannabinoids interact with cannabinoid receptors of the endocannabinoid system in different ways, and this is why different cannabinoids and combinations of them have the potential for different and unique effects on our bodies.
The volume of research that has been on done on CBGa is small compared to cannabinoids like THC or CBD, however there are a list of promising results so far. One study, for example, found CBGa to reduce seizures in mice and to interact with numerous epilepsy relevant neuro-chemical mechanisms.
Like other cannabinoids, CBGa has demonstrated anti-inflammatory properties. Another study has suggested that CBGa reduces the activity of an enzyme that is associated with many diabetic complications and might be involved in the metabolism of fats in the body. CBGa is also being investigated for colon cancer. Researchers have discovered cytotoxic effects from CBGa and it may even prevent the growth and proliferation of polyps.
CBGa is considered the parent of all other cannabinoids. Consider that the cannabis plant must first uptake elements and compounds through its root system, which it then uses to create chlorophyll, new leaves and flowers, trichomes, and the cannabinoids themselves. CBGa is the first cannabinoid that the cannabis plant fabricates, and it uses this cannabinoid as the foundation for constructing other cannabinoids.
The flowers and concentrates that the vast majority of the world consumes do not have any CBGa in them. Mature cannabis plants have undergone further biosynthesis of CBGa until it has been turned into other cannabinoids. This being the case, any substantial quantities of CBGa are even further complicated to get your hands on because it quickly degrades into CBG if processed in to concentrate haphazardly, if it is smoked, or otherwise consumed in any way other than eating it.
Fortunately, there are a few breeders in the world who have managed to create genetics which mature with a high quantity of CBGa. Seedstockers has a couple of these genetics available, CBG Zerodue, for example, and they are specifically designed so that the plant stops at CBGa and doesn’t continue biosynthesis into other cannabinoids.
Much like CBD and many other cannabinoids, CBDa has a long list of possible benefits, and might be used for anti-inflammation, seizures, treatment of anxiety, and even treating tumors. In fact, there has been evidence that CBDa works just as well or better than CBD when treating certain epileptic conditions. It seems that it might have a higher bio-availability as well as be faster acting that CBD.
The various studies we’ve done all point towards CBDa being just as powerful, or even more powerful than CBD, in almost all of the areas that are being examined for its use.
CBDa is about as difficult to get your hands on as THCa, because its most abundant on fresh plant material which was just harvested at peak maturation. After the trichomes of the cannabis plant have synthesized CBGa, the next step of biosynthesis is CBG. This version of CBD which has had a carboxyl group removed, is used to build either THCa, CBDa, CBCa, etc, depending on the genetic information contained within the plant.
Because of the explosion of CBD breeding programs around the world, finding a plant that produces high amounts of CBDa instead of high amounts of THCa is becoming easier and easier. Genetics, like CBD Critical XXL from Seedstockers, have been strictly developed in order to keep THCa levels so low as to be legal virtually world-wide while producing tons of CBDa.